Patents Assigned to ABEXXA BIOLOGICS, INC.
  • Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
    Patent number: 10981996
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: April 20, 2021
    Assignee: ABEXXA BIOLOGICS, INC.
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
    Patent number: 10981997
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: April 20, 2021
    Assignee: ABEXXA BIOLOGICS, INC.
    Inventors: Jon Weidanz, Katherine Upchurch-Ange